Valuation (86%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 19.26 | N/A |
| PEG Ratio (TTM) | 0.89 | N/A |
| P/S Ratio (TTM) | 0.46 | N/A |
| P/B Ratio (TTM) | 1.30 | N/A |
| P/FCF Ratio (TTM) | 6.55 | N/A |
| Price to 5YR AVG Earnings Ratio | 20.36 | N/A |
| Price to 5YR AVG FCF Ratio | 13.22 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.31% | N/A |
| ROE (TTM) | 6.75% | N/A |
| Net Profit Margin (TTM) | 2.37% | N/A |
| ROIC 5YR AVG | 9.27% | N/A |
Growth (85%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 189.80% | 59.03% | 19.58% |
| Revenue | 2.74% | 16.85% | 10.44% |
| Net Income | 185.01% | 60.95% | 20.34% |
| Cash Flow | -16.93% | 16.25% | 612.91% |
Health (74%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.86 | N/A |
| Quick Ratio (TTM) | 1.87 | N/A |
| D/E Ratio (TTM) | 0.42 | N/A |
| Interest Coverage (TTM) | 3.61 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 3.27 | N/A |
| LTL to 5YR AVG FCF | 5.10 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.35% | N/A |